Abstract:Abstract Background: Pancreatic cancer is a highly aggressive, rapidly progressing fatal digestive tract tumor. Cancer-associated fibroblasts form a barrier to the penetration of drugs or therapeutic immune cells. Therefore, the inhibition of tumors by modulating CAFs or overcoming their barrier effect is a new tool for tumor therapy. This study aimed to reveal the efficiency of graphene fluorescent nanoparticles targeting cancer-associated fibroblasts and tumor cells and demonstrate the application prospects of nanomedicine. Methods: We observed the co-localization effect of synthetic GFNPs on tumor cells and Cancer-associated fibroblasts in primary and metastatic pancreatic cancer, and synthesized a new nano-drug based on GFNPs and gemcitabine. In vivo imaging system and confocal laser scanning microscope were used for observing the location of GFNPs in tissues. Immunofluorescence staining and Halo analysis are used to observe and count the co-location of GFNPs in the tumor microenvironment. Results: GFNPs is not only abundantly deposited nearby tumor vessels but also penetrate tumor tissues to reach those regions far away from tumor vessels. Tagging data are as follows, GFNPs can label up to 30% of tumor cells or cancer-associated fibroblast cells inside human pancreatic cancer tissue and mouse tumor metastasis tissue. Over 60% of cancer-associated fibroblast cells in orthotopic pancreatic tumor tissues were marked by GFNPs. GFNPs localize in the nuclei of both αSMA-CAFs and adjacent tumor cells, then the fluorescence signal intensity was proportional to the tumor development cycle. The differences in the co-localization of GFNPs with the nuclei of positive Ki67-expressing tumor cells in primary and metastatic pancreatic cancer were investigated in-depth, fully illustrating that the spatial location of GFNPs in the TME is closely related to the degree of tumor differentiation and progression, guiding the diagnosis of clinical tumors. Based on the dual targeting characteristics of GFNPs targeting CAFs and tumor cells, we combined GFNPs with gemcitabine to form a new nano-drug with an effective reduction of tumor volume and fewer side effects. Conclusion: This study will provide useful insights into a dual-targeting strategy utilized in the field of pancreatic cancer therapy by targeting both CAFs and pancreatic cancer cells simultaneously.

Targeted Fluorescence Imaging and Anti-Tumor Effects of QDs-NGR Nanoparticles on Pancreatic Cancer Cells

Targeting Pancreatic Cancer with Magneto-Fluorescent Theranostic Gold Nanoshells.

Effects of QDs@Gd3+-NGR on Targeted Fluorescence-Magnetic Resonance Imaging and Inhibition of Pancreatic Cancer Cells

Targeted Fluorescence Imaging and Biological Effects of Peptide Conjugated Quantum Dots on Pancreatic Cancer Cells.

Drug delivery particles for targeted imaging-guided photothermal/chemotherapy synergy cancer therapy

Suppression of Pancreatic Tumor Growth by Targeted Arsenic Delivery with Anti-Cd44v6 Single Chain Antibody Conjugated Nanoparticles

Rgd-Conjugated Albumin Nanoparticles As A Novel Delivery Vehicle in Pancreatic Cancer Therapy

Effects of Arginine-Glycine-aspartic Acid Peptide-Conjugated Quantum Dots-Induced Photodynamic Therapy on Pancreatic Carcinoma in Vivo.

Biodistribution and Toxicity Assessment of Intratumorally Injected Arginine-Glycine-aspartic Acid Peptide Conjugated to CdSe/ZnS Quantum Dots in Mice Bearing Pancreatic Neoplasm

Photodynamic Therapy Using RGD-Functionalized Quantum Dots Elicit a Potent Immune Response in a Syngeneic Mouse Model of Pancreatic Cancer

IGF1 Receptor Targeted Theranostic Nanoparticles for Targeted and Image-Guided Therapy of Pancreatic Cancer.

Aggregation Induced Emission Fluorogens Based Nanotheranostics for Targeted and Imaging-Guided Chemo-Photothermal Combination Therapy

A GPC1-targeted and gemcitabine-loaded biocompatible nanoplatform for pancreatic cancer multimodal imaging and therapy.

In Vivo Near Infrared Fluorescence Imaging and Dynamic Quantification of Pancreatic Metastatic Tumors Using Folic Acid Conjugated Biodegradable Mesoporous Silica Nanoparticles.

Efficacy of Quantum Dots-RGD Based Photodynamic Therapy Combined with Gemcitabine for Treatment of Pancreatic Cancer Xenograft in Nude Mice

Graphene Fluorescent Nanoparticles Efficiently Targeting Cancer-Associated Fibroblasts and Pancreatic Cancer Cells

A carbonic anhydrase-targeted NIR-II fluorescent cisplatin theranostic nanoparticle for combined therapy of pancreatic tumors

Development of Dual Diagnostic-Therapeutic Nanoformulation Effective Against Pancreatic Cancer in Animal Model

IGF1 receptor-targeted black TiO2 nanoprobes for MRI-guided synergetic photothermal-chemotherapy in drug resistant pancreatic tumor.

Theranostic Nanoparticles Enabling the Release of Phosphorylated Gemcitabine for Advanced Pancreatic Cancer Therapy

Efficacy of NGR Peptide-Modified PEGylated Quantum Dots for Crossing the Blood–brain Barrier and Targeted Fluorescence Imaging of Glioma and Tumor Vasculature